Women receiving 1mg daily AOD 9604 achieved a mean body fat reduction of 2.6% compared to 0.4% in the placebo group
Retrieved 9 November 2019
AOD-9604 directly targets fat tissue without affecting GH/IGF-1 axis, making it a more selective option for pure fat metabolism enhancement without hormonal changes
STORE BETWEEN 15C AND 25C, OUT OF THE REACH OF CHILDREN Made in Canada/Fabrique au Canada Vendor 1-888-446-8874 NUTRICORP INTERNATIONAL, WINDSOR ONTARIO N8W 5B5 K2E 1C5, Canada* faisant affaire au Quebec sous le nom Les Entrepots Costce DO NOT USE IF SEAL UNDER CAP IS BROKEN
Dispose of the syringe and the solution in a proper sharps container and start over
Yore MM, Syed I, Moraes-Vieira PM, Zhang T, Herman MA, Homan EA, et al